Author Correction: Engineered hypoxia-responsive albumin nanoparticles mediating mitophagy regulation for cancer therapy.
- Published in:
- 2025
- By:
- Publication type:
- Correction Notice
Works by Huang, Qili
Results: 7
1
2
Engineered hypoxia-responsive albumin nanoparticles mediating mitophagy regulation for cancer therapy.
- Published in:
- Nature Communications, 2025, v. 16, n. 1, p. 1, doi. 10.1038/s41467-025-55905-y
- By:
- Publication type:
- Article
3
Vaspin Alleviates Sepsis-Induced Cardiac Injury and Cardiac Inflammation by Inhibiting Kallikrein 7 in Mice.
- Published in:
- Mediators of Inflammation, 2022, p. 1, doi. 10.1155/2022/1149582
- By:
- Publication type:
- Article
4
High-mobility group box 1 and its related receptors: potential therapeutic targets for contrast-induced acute kidney injury.
- Published in:
- International Urology & Nephrology, 2024, v. 56, n. 7, p. 2291, doi. 10.1007/s11255-024-03981-2
- By:
- Publication type:
- Article
5
High mobility group box 1 and homocysteine as preprocedural predictors for contrast-induced acute kidney injury after percutaneous coronary artery intervention.
- Published in:
- International Urology & Nephrology, 2022, v. 54, n. 7, p. 1663, doi. 10.1007/s11255-021-03050-y
- By:
- Publication type:
- Article
6
Multifunctional Mesoporous Polydopamine‐Based Systematic Delivery of STING Agonist for Enhanced Synergistic Photothermal‐Immunotherapy.
- Published in:
- Advanced Functional Materials, 2024, v. 34, n. 1, p. 1, doi. 10.1002/adfm.202307241
- By:
- Publication type:
- Article
7
Gender disparities in patients treated with veno-arterial ECMO for cardiogenic shock complicating acute myocardial infarction.
- Published in:
- Frontiers in Cardiovascular Medicine, 2025, p. 1, doi. 10.3389/fcvm.2025.1461580
- By:
- Publication type:
- Article